SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,860 | -12.9% | 22,150 | +16.7% | 0.00% | – |
| Q2 2023 | $88,266 | +24.5% | 18,982 | +23.7% | 0.00% | – |
| Q1 2023 | $70,908 | -34.9% | 15,348 | +13.9% | 0.00% | – |
| Q4 2022 | $108,870 | +87.7% | 13,474 | +29.7% | 0.00% | – |
| Q3 2022 | $58,000 | -73.5% | 10,392 | -61.0% | 0.00% | – |
| Q1 2022 | $219,000 | -61.0% | 26,632 | -29.5% | 0.00% | – |
| Q4 2021 | $562,000 | -54.9% | 37,769 | -42.7% | 0.00% | -100.0% |
| Q3 2021 | $1,246,000 | -1.2% | 65,942 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,261,000 | – | 67,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |